Furthermore, Rab25 interacted with α5β1 integrin and regulated the trafficking of this molecule, which promoted tumour progression in ovarian cancer cells.9 In our previous study, Rab25 was a candidate oncogene in NSCLC, and its driving role in EGFR‐TKI resistance was investigated. Here, RAB25 is linked to ovarian carcinoma.